Atherosclerosis is a chronic inflammatory disease of the arterial wall, and the activation of NF-κB has been shown to be involved in all stages of the development of atherosclerosis through mediating downstream canonical and non-canonical signaling pathways [78,79]. Here, NFKB1 is linked to atherosclerosis.